Navigation Links
Encision's Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress
Date:11/17/2010

BOULDER, Colo., Nov. 17, 2010 /PRNewswire/ -- Active electrode monitoring developed and manufactured by Boulder-based Encision Inc. (Pink Sheets: ECIA), is the only monopolar energy technology proposed as a solution to eliminate visceral burns during Single Port Laparoscopy according to a recent study presentation.  Encision is a medical device company owning patented surgical technology that is emerging as a standard of care in minimally invasive surgery.

The recommendations come as a result of a study reported by Dr. Basim Abu-Rafea at the 39th  American Association of Gynecological Laparoscopists Global Congress of Minimally Invasive Gynecology.  Dr. Abu-Rafea's paper, Single Port Laparoscopy and Monopolar Electrosurgery May Result in Visceral Burns, examined the effects of monopolar electrosurgery on various tissues/organs during simulated single port laparoscopic surgery in vitro and in vivo.

Dr. Abu-Rafea's conclusion was that "Monopolar electrosurgery during endoscopic surgery, compared with other energy sources, is associated with unique inherent risks and complications due to inadvertent direct coupling, capacitive coupling and insulation failure."  Dr. Abu-Rafea continued, "These dangers become particularly important with the emergence of single port laparoscopy which requires close proximity and crossing of multiple intra-abdominal instruments."  

Dr. Abu-Rafea also added, "During single port laparoscopy and use of monopolar energy, the proximity and crossing of instruments generates capacitive and/or direct coupled currents which may cause visceral burns.  Proposed solutions include the use of active electrode monitoring when performing single port laparoscopy to prevent capacitive coupling and direct coupling or consider using other forms of energy such as harmonic or bipolar."  

Jack Serino, Encision's president and CEO, responded in saying, "We are pleased that Encision's active electrode monitoring technology was again recognized as an important consideration to avoid inadvertent patient burns with the growing popularity of single port laparoscopy."

Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. The Company pioneered the development of patented AEM® Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in our filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether as a result of the receipt of new information, future events, or otherwise.

CONTACT:

Marcia McHaffie, Encision Inc., 303-444-2600, mmchaffie@encision.com




'/>"/>
SOURCE Encision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
2. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
3. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
4. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
5. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
6. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
7. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
8. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
9. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
10. Going Beyond Spa Day: Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits
11. Radioactive Seed Therapy Shows Significant Reduction in Lung Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016 Intec Pharma ... clinical-stage biopharmaceutical company, today announced the appointment of ... Affairs. "Ms. Strauss-Levy has 15 years of ... established an outstanding track record, having supported the advancement ... approval processes in the United States ...
(Date:5/2/2016)... -- Leading Economies with Fastest Real GDP Annual Percentage Change, 2015  ... Ireland 7.8 India 7.3, , Source: IMF and TechSci Research ... of Brazil , Russia , ... , registered the fastest GDP growth during the first decade of the ... recession in Brazil and Russia , ...
(Date:4/29/2016)... COUNTY, Calif. , April 29, 2016 /PRNewswire/ ... industry is projected to shift from systems dependent ... replace all types of modality CRT Medical monitors ... Although there are a host of foreseeable benefits ... serious concern; will existing modalities have to be ...
Breaking Medicine Technology:
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ProIntro ... Final Cut Pro X. Pixel Film Studios’ titles allow users to add a terrifying ... basic elements such as boxes, lines and accents. To add greater contrast, all the ...
(Date:5/3/2016)... ... ... Sue Desmond-Hellmann, chief executive officer of the Bill & Melinda Gates Foundation, will call ... keynote address at Georgia State University’s spring commencement on Saturday, May 7 ... a scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s efforts to help more ...
(Date:5/3/2016)... ... 03, 2016 , ... Calvary Hospital recently hosted a reception to mark a ... unit located at Mary, Manning Walsh Home (MMW) in Manhattan. , During the ... half an hour, once a week. The music brings a lot of joy to ...
(Date:5/3/2016)... ... May 03, 2016 , ... Horizon Blue ... been honored as one of the nation’s most accomplished business technology innovators by ... received the recognition for technology achievements that have enabled the delivery of the ...
(Date:5/3/2016)... FL (PRWEB) , ... May 03, 2016 , ... ... leading innovative specialty pharmacies, will be represented at the 2016 Asembia Specialty ... Vegas. The Asembia Summit is the largest U.S. health care conference for the ...
Breaking Medicine News(10 mins):